Safety and efficacy of four drug regimens versus standardof care for the treatment of symptomatic outpatients with COVID19 A randomised openlabel multiarm phase 2 clinical trial
| dc.article.end-page | 14 | en |
| dc.article.start-page | 1 | en |
| dc.citation.doi | 10.1016/J.EBIOM.2022.104322 | en |
| dc.contributor.author | Nomathemba Chandiwana | en |
| dc.contributor.author | C Kruger | en |
| dc.contributor.author | H Johnstone | en |
| dc.contributor.author | M Chughlay | en |
| dc.contributor.author | C Ju | en |
| dc.contributor.author | Yengiwe Dineka | en |
| dc.contributor.author | E et al | en |
| dc.contributor.author | Willem Venter | en |
| dc.date.accessioned | 2024-05-08T10:38:02Z | |
| dc.date.available | 2024-05-08T10:38:02Z | |
| dc.faculty | FACULTY OF HEALTH SCIENCES | en |
| dc.identifier.citation | WOS | en |
| dc.identifier.issn | 2352-3964 | en |
| dc.identifier.uri | https://hdl.handle.net/10539/38431 | |
| dc.journal.title | Safety and efficacy of four drug regimens versus standardof care for the treatment of symptomatic outpatients with COVID19 A randomised openlabel multiarm phase 2 clinical trial | en |
| dc.journal.volume | 86 | en |
| dc.title | Safety and efficacy of four drug regimens versus standardof care for the treatment of symptomatic outpatients with COVID19 A randomised openlabel multiarm phase 2 clinical trial | en |
| dc.type | Journal Article | en |
Files
Original bundle
1 - 1 of 1
- Name:
- Journal Article.pdf
- Size:
- 533.9 KB
- Format:
- Adobe Portable Document Format
- Description:
- Bitstream uploaded by REST Client